FDA Inspection
BSP Pharmaceuticals SpABSP Pharmaceuticals SpA – FDA Inspection, Feb 29, 2024
Record Details
This FDA Inspection record concerns BSP Pharmaceuticals SpA, with an inspection on February 29, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 3b6d1849-e7b8-40f9-96cc-4e6bb3d55d8c
Inspection Facts
- Inspection number
- 1232171
- FDA center
- Human Drugs
Other FDA inspections of BSP Pharmaceuticals SpA
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | Not classified | Office of Inspections and Investigations | |
| October 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSP Pharmaceuticals SpA
- FDA Inspection 1172555 - 2021-11-12
- FDA Inspection 1071722 - 2018-09-21
- FDA Inspection 1091112 - 2017-10-20
- FDA Inspection 1016102 - 2016-12-16
- FDA Inspection 935609 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.